Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,745 USD | +12,98% | -9,10% | +6,39% |
18/04 | Ocular Therapeutix, Inc. Kondigt positieve topline Fase 1 gegevens aan voor AXPAXLI? in diabetische retinopathie | CI |
15/04 | Ocular Therapeutix, Inc. Kondigt wijzigingen in de leiding aan | CI |
Vakgebied
Aantal werknemers: 267
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bioresorbable Hydrogel Platform Technology
99,0
%
| 50 | 98,0 % | 58 | 99,0 % | +14,69% |
Collaboration
1,0
%
| 1 | 2,0 % | 1 | 1,0 % | -44,74% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 51 | 100,0 % | 58 | 100,0 % | +13,49% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 25-09-17 |
Chief Tech/Sci/R&D Officer | - | 28-09-21 | |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 08-01-21 |
Jeffrey S. Heier
CTO | Chief Tech/Sci/R&D Officer | 63 | 11-09-15 |
Peter Jarrett
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-07 |
Scott Corning
IRO | Public Communications Contact | - | 01-01-10 |
Tracy Smith
HRO | Human Resources Officer | - | 01-09-20 |
Peter K. Kaiser
PRN | Corporate Officer/Principal | - | 22/02 |
General Counsel | 64 | 25-08-20 | |
Corporate Officer/Principal | 62 | 11-07-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 10-07-23 |
Director/Board Member | 76 | 05-11-12 | |
Merilee Raines
BRD | Director/Board Member | 68 | 20-09-21 |
Director/Board Member | 55 | 01-01-08 | |
Leslie Williams
BRD | Director/Board Member | 64 | 20-03-19 |
Jeffrey S. Heier
CTO | Chief Tech/Sci/R&D Officer | 63 | 11-09-15 |
Pravin Dugel
CEO | Chief Executive Officer | 60 | 21/02 |
Seung Suh Hong
BRD | Director/Board Member | 66 | 11-06-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 148 627 439 | 143 157 197 ( 96,32 %) | 0 | 96,32 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,39% | 734 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers OCUL
- Onderneming Ocular Therapeutix, Inc.